bw-755c has been researched along with Inhalation Injury, Smoke in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hales, CA; Hutchison, WG; Mahoney, E; Musto, S | 1 |
Hales, CA; Hutchison, WG; Janssens, SP; Jung, W; Musto, SW; Spence, C; Witten, M | 1 |
2 other study(ies) available for bw-755c and Inhalation Injury, Smoke
Article | Year |
---|---|
BW-755C diminishes smoke-induced pulmonary edema.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Blood Pressure; Body Fluids; Cardiac Output; Eicosanoids; Gossypium; Indomethacin; Pulmonary Circulation; Pulmonary Edema; Pulmonary Wedge Pressure; Sheep; Smoke Inhalation Injury; Vascular Resistance | 1995 |
Cyclooxygenase and lipoxygenase inhibition by BW-755C reduces acrolein smoke-induced acute lung injury.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acrolein; Animals; Benzofurans; Blood Proteins; Cyclooxygenase Inhibitors; Eicosanoids; Indomethacin; Inflammation Mediators; Lipoxygenase Inhibitors; Lymph; Oxygen Consumption; Pulmonary Circulation; Sheep; Smoke Inhalation Injury; Thromboxane-A Synthase; Vascular Resistance | 1994 |